These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 664625)
1. Srategy of leprosy control. WHO Chron; 1978 May; 32(5):193-9. PubMed ID: 664625 [No Abstract] [Full Text] [Related]
2. The schizophrenic career of a "monster drug". Crawford CL Pediatrics; 2003 Mar; 111(3):712. PubMed ID: 12612270 [No Abstract] [Full Text] [Related]
3. Effect of zafirlukast on leprosy reactions. Vides EA; Cabrera A; Ahern KP; Levis WR Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633 [No Abstract] [Full Text] [Related]
4. [Chemotherapy of leprosy. I. Sulfones and sulfonamides]. Leiker DL Ned Tijdschr Geneeskd; 1979 Jun; 123(23):969-72. PubMed ID: 460449 [No Abstract] [Full Text] [Related]
5. [Histoid leprosy with erythema nodosum leprosum]. Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700 [TBL] [Abstract][Full Text] [Related]
6. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. Chen XS; Li WZ; Jiang C; Ye GY Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910 [TBL] [Abstract][Full Text] [Related]
7. The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control. Levy L Ethiop Med J; 1985 Jan; 23(1):31-42. PubMed ID: 3965285 [No Abstract] [Full Text] [Related]
8. Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser; 1982; 675():1-33. PubMed ID: 6806990 [No Abstract] [Full Text] [Related]
9. Lepromatous leprosy in Saudi female from central region. al-Majed S J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331 [TBL] [Abstract][Full Text] [Related]
10. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?]. Sheskin J; Mückter H; Frankus E Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166 [No Abstract] [Full Text] [Related]
11. Treatment of leprosy: science or politics? Naafs B Trop Med Int Health; 2006 Mar; 11(3):268-78. PubMed ID: 16553906 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of leprosy in relation to control. Report of a WHO Study Group. World Health Organ Tech Rep Ser; 1985; 716():1-60. PubMed ID: 3925646 [No Abstract] [Full Text] [Related]
13. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472 [No Abstract] [Full Text] [Related]
14. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
15. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]